|
Volumn 10, Issue , 2009, Pages
|
Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: Protocol of SECETCM-HF
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUYIQIANGXIN;
CHINESE DRUG;
DANHONG;
DIGITALIS;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
PLACEBO;
QILIQIANGXIN;
SHENFU;
SHENMAI;
UNCLASSIFIED DRUG;
VASODILATOR AGENT;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CHINESE MEDICINE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HEART FAILURE;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL RESEARCH;
METHODOLOGY;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
CHINA;
COMPARATIVE STUDY;
CULTURAL ANTHROPOLOGY;
FOLLOW UP;
MORTALITY;
QUALITY OF LIFE;
CHINA;
FOLLOW-UP STUDIES;
HEART FAILURE;
HUMANS;
MEDICINE, CHINESE TRADITIONAL;
QUALITY OF LIFE;
WESTERN WORLD;
|
EID: 74549160851
PISSN: 17456215
EISSN: 17456215
Source Type: Journal
DOI: 10.1186/1745-6215-10-122 Document Type: Article |
Times cited : (11)
|
References (13)
|